Loading …
Never Run Out Of Buyers To Sell To.

Aytu BioPharma (NASDAQ: AYTU) is a dynamic & growing specialty biopharmaceutical company focused on advancing innovative medicines for complex central nervous system (CNS) diseases to improve the quality of life for patients.
Annual Revenue$50M to $100M
Estimated OwnershipPublicBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.